HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giancarlo Comi Selected Research

Glatiramer Acetate (Copaxone)

11/2021Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis.
2/2017Long-term safety and tolerability of glatiramer acetate 20 mg/ml in the treatment of relapsing forms of multiple sclerosis.
11/2015Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis.
7/2013Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome.
10/2012Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study.
1/2011Phase III dose-comparison study of glatiramer acetate for multiple sclerosis.
4/2010Freedom from disease activity in multiple sclerosis.
10/2009250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study.
6/2009Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experience.
9/2008Clinical and conventional MRI predictors of disability and brain atrophy accumulation in RRMS. A large scale, short-term follow-up study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giancarlo Comi Research Topics

Disease

158Multiple Sclerosis
11/2022 - 04/2003
42Relapsing-Remitting Multiple Sclerosis
10/2022 - 03/2006
14Inflammation (Inflammations)
02/2022 - 12/2002
13Disease Progression
11/2019 - 06/2003
12Stroke (Strokes)
07/2021 - 08/2008
12Alzheimer Disease (Alzheimer's Disease)
01/2020 - 02/2003
11COVID-19
07/2022 - 01/2020
11Demyelinating Diseases (Demyelinating Disease)
01/2022 - 06/2003
11Atrophy
01/2020 - 06/2005
10Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2022 - 05/2004
9Infections
01/2022 - 02/2010
8Optic Neuritis (Retrobulbar Neuritis)
12/2021 - 04/2016
7Progressive Multifocal Leukoencephalopathy
02/2022 - 01/2014
7Neuroinflammatory Diseases
01/2021 - 03/2009
6Ischemic Stroke
01/2021 - 01/2009
6Parkinson Disease (Parkinson's Disease)
01/2020 - 03/2013
6Cognitive Dysfunction
01/2020 - 11/2010
6Neoplasms (Cancer)
04/2019 - 01/2013
6Dementia (Dementias)
01/2019 - 01/2016
6Migraine Disorders (Migraine)
10/2016 - 05/2008
5Fatigue
12/2018 - 11/2002
5Headache (Headaches)
04/2016 - 05/2008
5Epilepsy (Aura)
02/2016 - 11/2012
4Lymphopenia (Lymphocytopenia)
01/2020 - 02/2010
4Pain (Aches)
12/2018 - 09/2013
4Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2018 - 10/2009
4Chronic Progressive Multiple Sclerosis
10/2017 - 09/2004
4Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
03/2017 - 04/2012
3Macular Edema
06/2021 - 02/2010
3Spontaneous Abortion (Miscarriage)
01/2020 - 10/2012
3Atrioventricular Block
11/2019 - 02/2010
3Herpes Zoster
04/2019 - 02/2010
3Brain Diseases (Brain Disorder)
01/2019 - 10/2008
3Polyneuropathies (Polyneuropathy)
01/2019 - 12/2007
3Frontotemporal Dementia (Semantic Dementia)
01/2017 - 01/2012
3Primary Progressive Aphasia
01/2015 - 01/2012
3Pathologic Processes
08/2014 - 12/2011
2Autoimmune Diseases (Autoimmune Disease)
01/2022 - 02/2015
2Ganglion Cysts (Ganglion)
12/2021 - 01/2017
2Neurodegenerative Diseases (Neurodegenerative Disease)
10/2021 - 12/2017
2Opportunistic Infections (Opportunistic Infection)
11/2019 - 04/2019
2Motor Neuron Disease (Primary Lateral Sclerosis)
01/2019 - 10/2009
2Immune Reconstitution Inflammatory Syndrome
01/2019 - 01/2014
2Dyskinesias (Dyskinesia)
12/2017 - 03/2013
2Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
05/2017 - 11/2003

Drug/Important Bio-Agent (IBA)

24Biomarkers (Surrogate Marker)IBA
12/2021 - 06/2005
21Fingolimod Hydrochloride (FTY720)FDA Link
10/2022 - 09/2006
20Natalizumab (Tysabri)FDA Link
11/2022 - 10/2009
18InterferonsIBA
11/2021 - 06/2003
17Interferon-betaIBA
01/2022 - 05/2005
17CladribineFDA LinkGeneric
11/2021 - 02/2010
16teriflunomideIBA
11/2020 - 10/2011
15Glatiramer Acetate (Copaxone)FDA Link
11/2021 - 11/2002
14TabletsIBA
01/2021 - 02/2010
13Interferon beta-1aFDA Link
01/2022 - 10/2004
12Pharmaceutical PreparationsIBA
01/2021 - 10/2004
8ozanimodIBA
10/2022 - 04/2016
7laquinimodIBA
04/2022 - 01/2012
7ocrelizumabIBA
01/2022 - 01/2017
7Alemtuzumab (Campath)FDA Link
01/2022 - 01/2020
7AntibodiesIBA
01/2022 - 07/2003
6Retinaldehyde (Retinal)IBA
12/2021 - 05/2016
6Oligoclonal BandsIBA
12/2021 - 01/2004
6GadoliniumIBA
12/2021 - 11/2012
5Myelin-Oligodendrocyte GlycoproteinIBA
01/2022 - 05/2004
5Messenger RNA (mRNA)IBA
10/2021 - 05/2004
5Interferon beta-1b (Betaseron)FDA Link
12/2017 - 10/2009
5Proteins (Proteins, Gene)FDA Link
05/2017 - 01/2004
4Sphingosine-1-Phosphate ReceptorsIBA
06/2021 - 04/2016
4nabiximols (Sativex)IBA
01/2019 - 11/2015
4Immunologic Factors (Immunomodulators)IBA
01/2018 - 09/2014
4frovatriptan (Allegro)FDA Link
01/2017 - 08/2014
4Amyloid (Amyloid Fibrils)IBA
01/2017 - 02/2003
4Alanine Transaminase (SGPT)IBA
01/2017 - 03/2014
4Mitoxantrone (Novantrone)FDA LinkGeneric
05/2013 - 09/2008
3Rituximab (Mabthera)FDA Link
11/2021 - 05/2017
3siponimodIBA
11/2021 - 01/2020
3IronIBA
11/2015 - 01/2010
3Intravenous Immunoglobulins (IVIG)FDA Link
12/2010 - 11/2003
3Protons (Proton)IBA
10/2009 - 06/2003
2MethylprednisoloneFDA LinkGeneric
07/2022 - 01/2021
2VaccinesIBA
04/2022 - 01/2020
2Complement System Proteins (Complement)IBA
02/2022 - 09/2013
2nitazoxanide (NTZ)FDA Link
02/2022 - 03/2015
2Tissue Plasminogen Activator (Alteplase)FDA Link
01/2021 - 08/2013
2Glycoproteins (Glycoprotein)IBA
01/2021 - 01/2019
2HLA Antigens (Human Leukocyte Antigens)IBA
01/2021 - 10/2015
2salicylhydroxamic acid (SHAM)IBA
01/2020 - 11/2013
2CannabinoidsIBA
01/2019 - 11/2012
2CytokinesIBA
01/2018 - 05/2004
2SuspensionsIBA
01/2018 - 11/2015
2DNA-Binding Proteins (DNA Binding Protein)IBA
03/2017 - 01/2014

Therapy/Procedure

60Therapeutics
04/2022 - 02/2003
9Transcranial Magnetic Stimulation
07/2021 - 05/2013
5Transplantation
11/2017 - 08/2009
4Injections
07/2020 - 07/2013
3Neurological Rehabilitation
02/2022 - 01/2016
3Hematopoietic Stem Cell Transplantation
01/2021 - 03/2014
3Wearable Electronic Devices
07/2020 - 07/2019
3Stem Cell Transplantation
11/2017 - 06/2005